Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled...

por Sambunaris, Angelo, Gommoll, Carl, Chen, Changzheng, Greenberg, William M.
Publicado 2014

Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression

por Khan, Arif, Sambunaris, Angelo, Edwards, John, Ruth, Adam, Robinson, Donald S.
Publicado 2014

Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder

por Thase, Michael E., Gommoll, Carl, Chen, Changzheng, Kramer, Kenneth, Sambunaris, Angelo
Publicado 2016

Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study

por Gommoll, Carl, Forero, Giovanna, Mathews, Maju, Nunez, Rene, Tang, Xiongwen, Durgam, Suresh, Sambunaris, Angelo
Publicado 2015

A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder

por Sambunaris, Angelo, Bose, Anjana, Gommoll, Carl P., Chen, Changzheng, Greenberg, William M., Sheehan, David V.
Publicado 2014

Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study

por Wesnes, Keith A., Gommoll, Carl, Chen, Changzheng, Sambunaris, Angelo, McIntyre, Roger S., Harvey, Philip D.
Publicado 2017